INTRA CELLULAR THERAPIES INC's ticker is and the CUSIP is 46116X901. A total of 4 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $880 | +83.0% | 16,900 | +122.4% | 0.00% | – |
| Q2 2023 | $481 | -84.4% | 7,600 | -86.7% | 0.00% | -100.0% |
| Q1 2023 | $3,086 | +501.6% | 57,000 | +487.6% | 0.00% | +200.0% |
| Q4 2022 | $513 | -99.9% | 9,700 | -53.6% | 0.00% | 0.0% |
| Q3 2022 | $972,000 | -30.8% | 20,900 | -15.0% | 0.00% | 0.0% |
| Q2 2022 | $1,404,000 | -58.0% | 24,600 | -54.9% | 0.00% | -66.7% |
| Q1 2022 | $3,340,000 | -7.4% | 54,600 | -20.8% | 0.00% | -25.0% |
| Q4 2021 | $3,606,000 | +103.6% | 68,900 | +65.2% | 0.00% | +100.0% |
| Q3 2021 | $1,771,000 | +3.8% | 41,700 | -0.2% | 0.00% | 0.0% |
| Q2 2021 | $1,706,000 | +886.1% | 41,800 | +81860.8% | 0.00% | – |
| Q1 2021 | $173,000 | -65.5% | 51 | -67.7% | 0.00% | -100.0% |
| Q4 2020 | $502,000 | -65.1% | 158 | -71.8% | 0.00% | -50.0% |
| Q3 2020 | $1,439,000 | -33.9% | 561 | -33.8% | 0.00% | -33.3% |
| Q2 2020 | $2,176,000 | +425.6% | 848 | +214.1% | 0.00% | +200.0% |
| Q1 2020 | $414,000 | -91.1% | 270 | -80.0% | 0.00% | -90.0% |
| Q4 2019 | $4,642,000 | +1032.2% | 1,353 | +146.0% | 0.01% | +900.0% |
| Q3 2019 | $410,000 | -77.1% | 550 | -60.1% | 0.00% | -80.0% |
| Q2 2019 | $1,791,000 | +2.8% | 1,380 | -3.6% | 0.01% | 0.0% |
| Q1 2019 | $1,742,000 | +35.1% | 1,431 | +26.4% | 0.01% | +25.0% |
| Q4 2018 | $1,289,000 | +104.3% | 1,132 | +289.0% | 0.00% | +100.0% |
| Q3 2018 | $631,000 | -0.9% | 291 | -19.4% | 0.00% | 0.0% |
| Q2 2018 | $637,000 | +3881.2% | 361 | +77.0% | 0.00% | +100.0% |
| Q1 2018 | $16,000 | +166.7% | 204 | +787.0% | 0.00% | – |
| Q4 2017 | $6,000 | -70.0% | 23 | -79.5% | 0.00% | -100.0% |
| Q3 2017 | $20,000 | 0.0% | 112 | -36.7% | 0.00% | 0.0% |
| Q2 2017 | $20,000 | +400.0% | 177 | +1866.7% | 0.00% | – |
| Q1 2017 | $4,000 | -94.6% | 9 | -98.6% | 0.00% | -100.0% |
| Q4 2016 | $74,000 | +1133.3% | 638 | -7.7% | 0.00% | – |
| Q3 2016 | $6,000 | -96.2% | 691 | +80.4% | 0.00% | -100.0% |
| Q2 2016 | $156,000 | +609.1% | 383 | +152.0% | 0.01% | +400.0% |
| Q1 2016 | $22,000 | -82.5% | 152 | +21.6% | 0.00% | -80.0% |
| Q4 2015 | $126,000 | +162.5% | 125 | -34.9% | 0.01% | +150.0% |
| Q3 2015 | $48,000 | – | 192 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 43,500 | $2,355,525 | 0.01% |
| JANE STREET GROUP, LLC | 180,500 | $9,774,075 | 0.00% |
| SIMPLEX TRADING, LLC | 57,000 | $3,086 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |